Titre : Hépatite auto-immune

Hépatite auto-immune : Questions médicales fréquentes

Termes MeSH sélectionnés :

Digestive System
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hépatite auto-immune : Questions médicales les plus fréquentes", "headline": "Hépatite auto-immune : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hépatite auto-immune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-08", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hépatite auto-immune" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies auto-immunes", "url": "https://questionsmedicales.fr/mesh/D001327", "about": { "@type": "MedicalCondition", "name": "Maladies auto-immunes", "code": { "@type": "MedicalCode", "code": "D001327", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.111" } } }, "about": { "@type": "MedicalCondition", "name": "Hépatite auto-immune", "alternateName": "Hepatitis, Autoimmune", "code": { "@type": "MedicalCode", "code": "D019693", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ansgar W Lohse", "url": "https://questionsmedicales.fr/author/Ansgar%20W%20Lohse", "affiliation": { "@type": "Organization", "name": "1(st) Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; European Reference Network on Hepatological Diseases (ERN RARE-LIVER)." } }, { "@type": "Person", "name": "Gideon M Hirschfield", "url": "https://questionsmedicales.fr/author/Gideon%20M%20Hirschfield", "affiliation": { "@type": "Organization", "name": "Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Canada." } }, { "@type": "Person", "name": "Marco Lenzi", "url": "https://questionsmedicales.fr/author/Marco%20Lenzi", "affiliation": { "@type": "Organization", "name": "Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy." } }, { "@type": "Person", "name": "Christoph Schramm", "url": "https://questionsmedicales.fr/author/Christoph%20Schramm", "affiliation": { "@type": "Organization", "name": "1(st) Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Martin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; European Reference Network on Hepatological Diseases (ERN RARE-LIVER)." } }, { "@type": "Person", "name": "Michael A Heneghan", "url": "https://questionsmedicales.fr/author/Michael%20A%20Heneghan", "affiliation": { "@type": "Organization", "name": "Institute of Liver Studies, King's College Hospital, London, United Kingdom; European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Electronic address: michael.heneghan@nhs.net." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Chromosome Microarray Analysis and Exome Sequencing: Implementation in Prenatal Diagnosis of Fetuses with Digestive System Malformations.", "datePublished": "2023-09-26", "url": "https://questionsmedicales.fr/article/37895220", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/genes14101872" } }, { "@type": "ScholarlyArticle", "name": "Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37124722", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1155307" } }, { "@type": "ScholarlyArticle", "name": "The detrimental effects of micro-and nano-plastics on digestive system: An overview of oxidative stress-related adverse outcome pathway.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37003332", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.scitotenv.2023.163144" } }, { "@type": "ScholarlyArticle", "name": "Potential health risk of areca nut consumption: Hazardous effect of toxic alkaloids and aflatoxins on human digestive system.", "datePublished": "2022-10-03", "url": "https://questionsmedicales.fr/article/36461237", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.foodres.2022.112012" } }, { "@type": "ScholarlyArticle", "name": "Effect of different cadmium levels in Boletus griseus on bioaccessibility, bioavailability, and intestinal flora by establishing a complete bionic digestion system in vitro.", "datePublished": "2022-06-28", "url": "https://questionsmedicales.fr/article/35762635", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1750-3841.16231" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Maladies auto-immunes", "item": "https://questionsmedicales.fr/mesh/D001327" }, { "@type": "ListItem", "position": 4, "name": "Hépatite auto-immune", "item": "https://questionsmedicales.fr/mesh/D019693" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hépatite auto-immune - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hépatite auto-immune", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hépatite auto-immune", "description": "Comment diagnostiquer l'hépatite auto-immune ?\nQuels tests sanguins sont utilisés ?\nQuel rôle joue la biopsie dans le diagnostic ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on confondre cette hépatite avec d'autres ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Digestive+System&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hépatite auto-immune", "description": "Quels sont les symptômes courants ?\nLa fièvre est-elle un symptôme ?\nLes symptômes varient-ils selon les patients ?\nY a-t-il des symptômes spécifiques chez les femmes ?\nLes symptômes peuvent-ils s'aggraver ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Digestive+System&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hépatite auto-immune", "description": "Peut-on prévenir l'hépatite auto-immune ?\nLes vaccinations sont-elles utiles ?\nLe dépistage précoce est-il important ?\nLes habitudes alimentaires influencent-elles ?\nLe stress a-t-il un impact ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Digestive+System&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hépatite auto-immune", "description": "Quels traitements sont disponibles ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLe traitement est-il à vie ?\nDes traitements alternatifs existent-ils ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Digestive+System&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hépatite auto-immune", "description": "Quelles sont les complications possibles ?\nLa cirrhose est-elle réversible ?\nComment l'insuffisance hépatique se manifeste-t-elle ?\nLe cancer du foie est-il fréquent ?\nDes complications peuvent-elles survenir rapidement ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Digestive+System&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hépatite auto-immune", "description": "Quels sont les facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe a-t-il un impact sur le risque ?\nDes facteurs environnementaux sont-ils impliqués ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Digestive+System&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hépatite auto-immune ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, biopsies hépatiques et évaluation des symptômes." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent les anticorps antinucléaires et les anticorps anti-muscle lisse." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie permet d'évaluer l'inflammation et les lésions hépatiques au microscope." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fatigue et la jaunisse orientent vers l'hépatite auto-immune." } }, { "@type": "Question", "name": "Peut-on confondre cette hépatite avec d'autres ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec l'hépatite virale ou alcoolique sans tests appropriés." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et démangeaisons." } }, { "@type": "Question", "name": "La fièvre est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre peut survenir, souvent accompagnée d'autres symptômes d'inflammation." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les patients ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la combinaison des symptômes peuvent varier d'un patient à l'autre." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les femmes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes peuvent présenter des symptômes plus marqués, comme des troubles menstruels." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'aggraver et mener à des complications." } }, { "@type": "Question", "name": "Peut-on prévenir l'hépatite auto-immune ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de prévention spécifique, mais un mode de vie sain peut aider." } }, { "@type": "Question", "name": "Les vaccinations sont-elles utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations contre l'hépatite virale peuvent prévenir des complications hépatiques." } }, { "@type": "Question", "name": "Le dépistage précoce est-il important ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un dépistage précoce peut aider à gérer la maladie avant qu'elle ne progresse." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé du foie et réduire les risques." } }, { "@type": "Question", "name": "Le stress a-t-il un impact ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes, donc des techniques de gestion du stress sont bénéfiques." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des corticostéroïdes et des immunosuppresseurs pour réduire l'inflammation." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la plupart des patients répondent bien aux traitements, améliorant leur qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les corticostéroïdes peuvent causer des effets secondaires comme la prise de poids." } }, { "@type": "Question", "name": "Le traitement est-il à vie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais certains patients nécessitent un traitement à long terme pour contrôler la maladie." } }, { "@type": "Question", "name": "Des traitements alternatifs existent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches complémentaires comme la nutrition peuvent aider, mais nécessitent des études." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la cirrhose, l'insuffisance hépatique et le cancer du foie." } }, { "@type": "Question", "name": "La cirrhose est-elle réversible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la cirrhose est irréversible, mais un traitement peut ralentir sa progression." } }, { "@type": "Question", "name": "Comment l'insuffisance hépatique se manifeste-t-elle ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une fatigue extrême, une confusion et des saignements faciles." } }, { "@type": "Question", "name": "Le cancer du foie est-il fréquent ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Le cancer du foie peut survenir chez les patients avec hépatite auto-immune avancée." } }, { "@type": "Question", "name": "Des complications peuvent-elles survenir rapidement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent se développer rapidement sans traitement approprié." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, le sexe féminin et d'autres maladies auto-immunes." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hépatite auto-immune est plus fréquente chez les jeunes adultes et les adolescents." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies auto-immunes augmentent le risque d'hépatite auto-immune." } }, { "@type": "Question", "name": "Le sexe a-t-il un impact sur le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer une hépatite auto-immune que les hommes." } }, { "@type": "Question", "name": "Des facteurs environnementaux sont-ils impliqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections virales et des toxines environnementales peuvent déclencher la maladie." } } ] } ] }

Sources (10000 au total)

Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system.

To develop and validate a contrast-enhanced CT-based radiomics nomogram for the diagnosis of neuroendocrine carcinoma of the digestive system.... The clinical data and contrast-enhanced CT images of 60 patients with pathologically confirmed neuroendocrine carcinoma of the digestive system and 60 patients with non-neuroendocrine carcinoma of the... Logistic regression results showed that TNM stage (stage IV) (OR 6.8, 95% CI 1.320-43.164,... The nomogram constructed based on contrast-enhanced CT radiomics and clinical characteristics was able to effectively diagnose neuroendocrine carcinoma of the digestive system....

Effect of different cadmium levels in Boletus griseus on bioaccessibility, bioavailability, and intestinal flora by establishing a complete bionic digestion system in vitro.

The bioaccessibility and bioavailability of different cadmium (Cd) levels (low: 7.31 mg/kg, medium: 24.20 mg/kg, high: 41.64 mg/kg) in Boletus griseus were evaluated by establishing a bionic digestive...

A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system.

Both acute and chronic symptoms of oxaliplatin-induced peripheral neuropathy (OIPN) affect patients' treatment dose and duration as well as quality-of-life. Hand/foot-cooling has been shown to reduce ... In a monocentric, open-label phase II trial, patients with malignancies of the digestive system receiving oxaliplatin-based chemotherapy were randomly assigned to receive either continuous cooling of ... The intention-to-treat population included 39 patients in the hilotherapy group and 38 in the control group. The grade ≥2 neuropathy-free rate at 12 weeks was 100% in the experimental group versus 80.... In this first study on hand/foot-cooling in oxaliplatin alone, hilotherapy significantly reduced the incidence of grade ≥2 OIPN at 12 and 24 weeks. Hilotherapy also reduced acute OIPN symptoms and was...

[Work Participation after Multimodal Rehabilitation due to Diseases of the Digestive System. Representative Analyses using Routine Data of the German Pension Insurance].

Diseases of the digestive system such as Crohn's disease (CD) or ulcerative colitis (UC) are associated with problems in occupational participation, but they only make up a very small part of all reha... We used the rehabilitation statistics database of the German Pension Insurance. Patients were included with completed medical rehabilitation due to a disease of the digestive system in 2017. The analy... A total of 8,795 data sets were included in the analysis (CD: n=1,779, 20%; UC: n=1,438, 16%; DI: 1,282, 15%; PA: n=761, 9%). The average age in the groups ranged from 44 (CD) to 54 (DI) years; the pr... Two years after gastroenterological rehabilitation in Germany, 6 to 7 out of 10 affected persons return to stable work participation. Relevant influencing factors are the time of sick leave and the le...

Real-World Evidence for COVID-19 Delta Variant's Effects on the Digestive System and Protection of Inactivated Vaccines from a Medical Center in Yangzhou, China: A Retrospective Observational Study.

Coronavirus disease 2019 (COVID-19) is rapidly disseminated worldwide, and it continues to threaten global public health. Recently, the Delta variant has emerged as the most dreaded variant worldwide.... To evaluate the difference between mild illness group, moderate illness group, and severe or critical illness group, analysis of variance (ANOVA) was employed to compare the three groups' total gastro... Significant differences were observed in the abnormal ratio of alanine aminotransferase (ALT), total bilirubin (TBIL), direct bilirubin (DBIL), lactate dehydrogenase (LDH), and Interleukin 6 (IL-6) ra... In summary, serum AST, DBIL, LDH, and IL-6 levels are potential markers for distinguishing severe or critical patients in the early stage of the Delta variant infection. Additionally, changes in the l...

The Digestive System of the

Marine mammals play a critical ecological role as both predator and prey. They are divided into three groups that share similar adaptations to their aquatic life, but that have very different origins ...